Healthcare -
Biotechnology - NASDAQ - US
$ 8.92
12 %
$ 482 M
Market Cap
-5.22
P/E
STOK - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities STOK - Stoke Therapeutics, Inc.
131 M
LAST VALUE
68.07%
2 YEAR CAGR
-2.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR